FOR IMMEDIATE RELEASE
May 8, 2009
Relief for arthritis pain – without medication
For over eight years MyPhield technology has been making arthritis sufferers’ life easier
May 8, 2009, WINNIPEG – People who suffer from arthritis pain have few choices – it’s either medication or an operation – unless they’re among those who’ve heard about MyPhield technology.
MyPhield is a Class II medical device licensed by Health Canada for the treatment of pain resulting from arthritic conditions.
For 8 years, MyPhield technology was used successfully in 10,000 treatments at the BioResonance Pain Relief Center in Winnipeg as an alternative therapy for arthritis pain relief. Statistics compiled by a University of Manitoba professor from 1488 treatments at the clinic, showed significant positive changes in more than 80 per cent of patients, resulting in improved quality of life.
“The challenge with arthritis medications designed to treat the pain or lessen joint inflammation, are their potential side effects,” says Alan Kotowich. “People have been known to develop ulcers and suffer a variety of health issues in their effort to lessen their pain. But with MyPhield’s BioResonance treatments, there’s no medication and no side effects.”
The developers of MyPhield believed that if people were given the opportunity of lessening pain without medication, chronic arthritis sufferers would try BioResonance treatments, so they developed a device to be used by patients without having to go to a clinic. After only 2 – 3 weeks of treatments, and just 45 minutes each day, the results from MyPhield’s BioResonance device are significant.
“I can play bridge, work in my garden, pick up my grandchild, or wear my wedding rings again,” says Aileen. “If it wasn’t for BioResonance treatments, I’d be housebound… I’m very, very pleased with the results…”
What’s notable about Aileen is that she suffered from osteoarthritis in both knees for 30 years and was waiting for bilateral knee replacements. After receiving BioResonance treatments and while waiting for her replacements, she was able to decrease the dosage of Celebrex, continue to be active and improve her quality of life.
- 30 -
For further information or to arrange an interview contact:
Peter Turkington
Strategic Communications Solutions
ON BEHALF OF MYPHIELD TECHNOLOGY INC.
Direct Phone: 905.901.9218
Email: pturkington@stratcommsolutions.ca
